Lactante de 3-24 meses con fiebre sin foco en urgencias: características, tratamiento y evolución posterior

Anales de Pediatría - Tập 62 - Trang 522-528 - 2005
S. Mintegi Raso1, M. González Balenciaga1, A. Pérez Fernández1, J.I. Pijoán Zubizarreta2, S. Capapé Zache1, J. Benito Fernández1
1Urgencias de Pediatría. Hospital de Cruces. Bilbao. España
2Unidad de Epidemiología Clínica. Hospital de Cruces. Bilbao. España

Tài liệu tham khảo

Mintegi, 2004, Demanda y asistencia en un servicio de urgencies hospitalario, An Pediatr (Barc), 61, 156, 10.1016/S1695-4033(04)78374-5 Shapiro, 1986, Risk factors for development of bacterial meningitis among children with occult bacteremia, J Pediatr, 109, 15, 10.1016/S0022-3476(86)80564-9 Kaplan, 2004, Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine, Pediatrics, 113, 443, 10.1542/peds.113.3.443 Poehling, 2004, Population-based impact of pneumococcal conjugate vaccine in young children, Pediatrics, 114, 755, 10.1542/peds.2003-0592-F 2001, Sociedad Española de Urgencias de Pediatría. El niño febril. Resultados de un estudio multicéntrico, An Esp Pediatr, 55, 5, 10.1016/S1695-4033(01)77617-5 Baraff, 1993, Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research, Ann Emerg Med, 22, 1198, 10.1016/S0196-0644(05)80991-6 Klein JO, Pelton SI, Barnett E, Culpepper L, Shinefield H. Management of pediatric pneumococcal diseases in the era of the pneumococcal conjugate vaccine. Disponible en: http://www.medscape.com/viewprogram/2824_pnt [visitado el 07-09-04]. Baraff, 2003, Clinical policy for children younger than three years presenting to the emergency department with fever [editorial], Ann Emerg Med, 42, 546, 10.1067/S0196-0644(03)00754-6 Belfer, 2001, Management of febrile infants and children by pediatric emergency medicine and emergency medicine: Comparison with practice guidelines, Pediatr Emerg Care, 17, 83, 10.1097/00006565-200104000-00001 Isaacman, 2001, Comparative practice patterns of emergency medicine physicians and pediatric emergency medicine physicians managing fever in young children, Pediatrics, 108, 354, 10.1542/peds.108.2.354 Luszczak, 2001, Evaluation and management of infants and young children with fever, Am Fam Physician, 64, 1219 2000, Codificación diagnóstica en urgencias de pediatría, An Esp Pediatr, 53, 261, 10.1016/S1695-4033(00)77455-8 Overturf, 2000, Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis, Pediatrics, 106, 367, 10.1542/peds.106.2.367 Lee, 1998, Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era, Arch Pediatr Adolesc Med, 152, 624, 10.1001/archpedi.152.7.624 2003, Clinical policy for children younger than three years presenting to the emergency department with fever, Ann Emerg Med, 42, 530, 10.1067/S0196-0644(03)00628-0 Bachur, 1999, Occult pneumonias: Empiric chest radiographs in febrile children with leukocytosis, Ann Emerg Med, 33, 166, 10.1016/S0196-0644(99)70390-2 Baraff, 1999, Empiric chest radiographs in febrile children with leukocytosis, Ann Emerg Med, 33, 480, 10.1016/S0196-0644(99)70331-8 Green, 1999, Evaluation styles for well-appearing febrile children: Are you a “risk-minimizer” or a “test-minimizer”?, Ann Emerg Med, 33, 211, 10.1016/S0196-0644(99)70396-3 Kuppermann, 1999, Occult bacteremia in young febrile children, Pediatr Clin North Am, 46, 1073, 10.1016/S0031-3955(05)70176-0 Whitney, 2003, Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine, N Engl J Med, 348, 1737, 10.1056/NEJMoa022823 Lin, 2003, Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine, Pediatrics, 111, 896, 10.1542/peds.111.4.896 Baraff, 2000, Management of fever without source in infants and children, Ann Emerg Med, 36, 602, 10.1067/mem.2000.110820 Nigrovic LE, Malley R. Evaluation of the febrile child 3 to 36 months old in the era of pneumococcal conjugate vaccine: Focus on occult bacteremia. Clin Ped Emerg Med. 5:13-9. Lee, 2001, Management of febrile children in the age of conjugate pneumococcal vaccine: A cost-effectiveness analysis, Pediatrics, 108, 835, 10.1542/peds.108.4.835